PD-Rx Pharmaceuticals, Inc. (PDRX)

USD 2.75

(5.36%)

Long Term Debt Summary of PD-Rx Pharmaceuticals, Inc.

  • PD-Rx Pharmaceuticals, Inc.'s latest annual long term debt in 2022 was - USD , down 0.0% from previous year.
  • PD-Rx Pharmaceuticals, Inc.'s latest quarterly long term debt in 2022 FY was - USD , down 0.0% from previous quarter.
  • PD-Rx Pharmaceuticals, Inc. reported annual long term debt of - USD in 2021, down 0.0% from previous year.
  • PD-Rx Pharmaceuticals, Inc. reported annual long term debt of - USD in 2020, down -100.0% from previous year.
  • PD-Rx Pharmaceuticals, Inc. reported quarterly long term debt of - USD for 2021 FY, down 0.0% from previous quarter.
  • PD-Rx Pharmaceuticals, Inc. reported quarterly long term debt of - USD for 2020 FY, down -100.0% from previous quarter.

Annual Long Term Debt Chart of PD-Rx Pharmaceuticals, Inc. (2022 - 2012)

Historical Annual Long Term Debt of PD-Rx Pharmaceuticals, Inc. (2022 - 2012)

Year Long Term Debt Long Term Debt Growth
2022 - USD 0.0%
2021 - USD 0.0%
2020 - USD -100.0%
2019 933.7 Thousand USD 0.0%
2018 - USD 0.0%
2017 - USD 0.0%
2016 - USD 0.0%
2015 - USD 0.0%
2014 - USD 0.0%
2013 - USD 0.0%
2012 - USD 0.0%

Peer Long Term Debt Comparison of PD-Rx Pharmaceuticals, Inc.

Name Long Term Debt Long Term Debt Difference
China Medicine Corporation - USD NaN%
DH Enchantment Inc. - USD NaN%
Exlites Holdings International, Inc. - USD NaN%
Itonis, Inc. - USD NaN%
One Step Vending Corp. - USD NaN%
MediPal Holdings Corporation - USD NaN%
Pharmagen, Inc. 770.31 USD 100.0%
Suzuken Co., Ltd. - USD NaN%